- Home
- Novartis Ag
Insider Trading History of Novartis Ag
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Novartis Ag since 2011.
The trader's CIK number is 1114448.
At the time of the last reporting, Novartis Ag was the 10% Owner of Akouos, Inc.. (stock ticker symbol AKUS).
Also see all insider trading activities at Akouos, Inc..
Note that in the past
NOVARTIS AG also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Akouos, Inc. (AKUS) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | AKUS | 125,000 | $2,125,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ra Pharmaceuticals, Inc. (RARX) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | RARX | 0 | $0 | 294,195 | $6,734,930 | 0 | $0 |
| 2016 | RARX | 84,615 | $1,099,995 | 339 | $4,407 | 0 | $0 |
Yearly summary of insider trading at Galera Therapeutics, Inc. (GRTX) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | GRTX | 0 | $0 | 1,075,106 | $8,957,129 | 0 | $0 |
| 2019 | GRTX | 250,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aeglea Biotherapeutics, Inc. (AGLE) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | AGLE | 0 | $0 | 135,610 | $1,368,368 | 0 | $0 |
| 2016 | AGLE | 300,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aileron Therapeutics Inc (ALRN) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ALRN | 0 | $0 | 317,488 | $627,702 | 0 | $0 |
| 2018 | ALRN | 0 | $0 | 142,598 | $470,195 | 0 | $0 |
| 2017 | ALRN | 266,667 | $4,000,005 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NTLA | 0 | $0 | 1,523,000 | $27,870,900 | 0 | $0 |
| 2016 | NTLA | 277,777 | $4,999,986 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Surface Oncology, Inc. (SURF) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | SURF | 766,666 | $11,499,990 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Novus Therapeutics, Inc. (TKAI) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | TKAI | 0 | $0 | 150,870 | $2,163,271 | 0 | $0 |
| 2014 | TKAI | 325,000 | $4,875,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bicycle Therapeutics Plc (BCYC) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | BCYC | 168,630 | $2,360,820 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aerpio Pharmaceuticals, Inc. (ARPO) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ARPO | 0 | $0 | 1,750,446 | $1,773,156 | 0 | $0 |
| 2018 | ARPO | 0 | $0 | 5,300 | $20,670 | 0 | $0 |
| 2017 | ARPO | 560,000 | $2,800,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Proteostasis Therapeutics, Inc. (PTI) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | PTI | 375,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Nastech Pharmaceutical Co Inc (MRNA) by Novartis Ag
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | MRNA | 0 | $0 | 404,005 | $500,683 | 0 | $0 |
Insider trading activities at 12 companies by Novartis Ag:
1. Akouos, Inc. (AKUS)
2. Ra Pharmaceuticals, Inc. (RARX)
3. Galera Therapeutics, Inc. (GRTX)
4. Aeglea Biotherapeutics, Inc. (AGLE)
5. Aileron Therapeutics Inc (ALRN)
6. Intellia Therapeutics, Inc. (NTLA)
7. Surface Oncology, Inc. (SURF)
8. Novus Therapeutics, Inc. (TKAI)
9. Bicycle Therapeutics Plc (BCYC)
10. Aerpio Pharmaceuticals, Inc. (ARPO)
11. Proteostasis Therapeutics, Inc. (PTI)
12. Nastech Pharmaceutical Co Inc (MRNA)
Table 1. Insider trading of Akouos, Inc. (AKUS) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-30 | AKUS | Buy | 125,000 | 17.00 | 2,125,000 |
Table 2. Insider trading of Ra Pharmaceuticals, Inc. (RARX) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-06-19 | RARX | Sale | 3,220 | 22.02 | 70,897 |
| 2017-06-16 | RARX | Sale | 53,200 | 21.25 | 1,130,234 |
| 2017-06-08 | RARX | Sale | 700 | 22.00 | 15,400 |
| 2017-06-06 | RARX | Sale | 7,274 | 22.98 | 167,163 |
| 2017-06-07 | RARX | Sale | 4,840 | 22.11 | 106,997 |
| 2017-06-02 | RARX | Sale | 14,867 | 23.47 | 348,943 |
| 2017-06-05 | RARX | Sale | 4,780 | 23.11 | 110,489 |
| 2017-06-01 | RARX | Sale | 10,722 | 23.89 | 256,180 |
| 2017-05-31 | RARX | Sale | 35,539 | 23.94 | 850,910 |
| 2017-05-26 | RARX | Sale | 5,300 | 25.14 | 133,268 |
| 2017-05-25 | RARX | Sale | 53 | 25.00 | 1,325 |
| 2017-05-24 | RARX | Sale | 17,451 | 25.00 | 436,362 |
| 2017-05-18 | RARX | Sale | 9,019 | 25.50 | 229,966 |
| 2017-05-17 | RARX | Sale | 22,534 | 25.51 | 574,909 |
| 2017-05-16 | RARX | Sale | 20,081 | 26.33 | 528,732 |
| 2017-02-22 | RARX | Sale | 749 | 21.86 | 16,369 |
| 2017-02-23 | RARX | Sale | 4,999 | 21.04 | 105,158 |
| 2017-02-24 | RARX | Sale | 5,398 | 20.93 | 113,001 |
| 2017-02-27 | RARX | Sale | 57,844 | 20.96 | 1,212,294 |
| 2017-02-28 | RARX | Sale | 7,847 | 20.86 | 163,672 |
| 2017-03-01 | RARX | Sale | 7,778 | 20.91 | 162,661 |
| 2016-10-31 | RARX | Sale | 339 | 13.00 | 4,407 |
| 2016-10-31 | RARX | Buy | 84,615 | 13.00 | 1,099,995 |
Table 3. Insider trading of Galera Therapeutics, Inc. (GRTX) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-18 | GRTX | Sale | 900 | 9.04 | 8,135 |
| 2020-06-19 | GRTX | Sale | 1,001,312 | 8.25 | 8,260,824 |
| 2020-06-15 | GRTX | Sale | 6,164 | 9.05 | 55,784 |
| 2020-06-16 | GRTX | Sale | 8,600 | 9.30 | 79,980 |
| 2020-06-17 | GRTX | Sale | 4,622 | 9.27 | 42,845 |
| 2020-06-11 | GRTX | Sale | 7,200 | 9.21 | 66,312 |
| 2020-06-12 | GRTX | Sale | 1,500 | 9.19 | 13,785 |
| 2020-06-10 | GRTX | Sale | 8,532 | 9.46 | 80,712 |
| 2020-06-09 | GRTX | Sale | 7,000 | 9.38 | 65,660 |
| 2020-06-05 | GRTX | Sale | 8,652 | 9.66 | 83,578 |
| 2020-06-08 | GRTX | Sale | 5,659 | 9.66 | 54,665 |
| 2020-06-04 | GRTX | Sale | 4,088 | 9.55 | 39,040 |
| 2020-06-03 | GRTX | Sale | 5,208 | 9.78 | 50,934 |
| 2020-06-02 | GRTX | Sale | 5,669 | 9.68 | 54,875 |
| 2019-11-12 | GRTX | Buy | 250,000 | 12.00 | 3,000,000 |
Table 4. Insider trading of Aeglea Biotherapeutics, Inc. (AGLE) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-11 | AGLE | Sale | 19,550 | 10.06 | 196,673 |
| 2018-05-09 | AGLE | Sale | 51,230 | 10.11 | 517,935 |
| 2018-05-10 | AGLE | Sale | 22,725 | 10.13 | 230,204 |
| 2018-05-08 | AGLE | Sale | 26,557 | 10.03 | 266,366 |
| 2018-05-07 | AGLE | Sale | 15,548 | 10.11 | 157,190 |
| 2016-04-12 | AGLE | Buy | 300,000 | 10.00 | 3,000,000 |
Table 5. Insider trading of Aileron Therapeutics Inc (ALRN) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-04-01 | ALRN | Sale | 20,610 | 1.90 | 39,159 |
| 2019-03-29 | ALRN | Sale | 106,540 | 1.85 | 197,099 |
| 2019-03-13 | ALRN | Sale | 132,738 | 2.12 | 281,404 |
| 2019-03-14 | ALRN | Sale | 13,800 | 1.88 | 25,944 |
| 2019-03-15 | ALRN | Sale | 43,800 | 1.92 | 84,096 |
| 2018-08-20 | ALRN | Sale | 20,388 | 2.30 | 46,892 |
| 2018-08-17 | ALRN | Sale | 8,700 | 2.10 | 18,270 |
| 2018-08-16 | ALRN | Sale | 8,808 | 2.10 | 18,496 |
| 2018-08-14 | ALRN | Sale | 3,300 | 2.26 | 7,457 |
| 2018-08-15 | ALRN | Sale | 2,635 | 2.15 | 5,665 |
| 2018-08-10 | ALRN | Sale | 5,615 | 2.44 | 13,700 |
| 2018-08-13 | ALRN | Sale | 1,600 | 2.36 | 3,776 |
| 2018-08-09 | ALRN | Sale | 235 | 2.48 | 582 |
| 2018-08-08 | ALRN | Sale | 1,000 | 2.78 | 2,780 |
| 2018-08-06 | ALRN | Sale | 2,942 | 3.02 | 8,884 |
| 2018-08-07 | ALRN | Sale | 1,739 | 2.97 | 5,164 |
| 2018-08-01 | ALRN | Sale | 8,181 | 3.22 | 26,342 |
| 2018-07-31 | ALRN | Sale | 4,500 | 3.07 | 13,815 |
| 2018-07-27 | ALRN | Sale | 6,458 | 3.38 | 21,828 |
| 2018-07-30 | ALRN | Sale | 2,000 | 3.27 | 6,540 |
| 2018-07-25 | ALRN | Sale | 12,460 | 3.84 | 47,846 |
| 2018-07-26 | ALRN | Sale | 7,937 | 3.63 | 28,811 |
| 2018-07-23 | ALRN | Sale | 30,600 | 4.25 | 130,050 |
| 2018-07-24 | ALRN | Sale | 700 | 4.11 | 2,877 |
| 2018-07-17 | ALRN | Sale | 12,500 | 4.71 | 58,875 |
| 2018-07-16 | ALRN | Sale | 300 | 5.15 | 1,545 |
| 2017-07-05 | ALRN | Buy | 266,667 | 15.00 | 4,000,005 |
Table 6. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-12-12 | NTLA | Sale | 1,523,000 | 18.30 | 27,870,900 |
| 2016-05-11 | NTLA | Buy | 277,777 | 18.00 | 4,999,986 |
Table 7. Insider trading of Surface Oncology, Inc. (SURF) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-04-23 | SURF | Buy | 766,666 | 15.00 | 11,499,990 |
Table 8. Insider trading of Novus Therapeutics, Inc. (TKAI) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-07-15 | TKAI | Sale | 3,566 | 14.26 | 50,844 |
| 2015-07-14 | TKAI | Sale | 27,861 | 14.41 | 401,477 |
| 2015-07-13 | TKAI | Sale | 20,611 | 14.20 | 292,717 |
| 2015-06-16 | TKAI | Sale | 1,120 | 14.27 | 15,982 |
| 2014-06-15 | TKAI | Sale | 14,777 | 14.20 | 209,833 |
| 2015-06-12 | TKAI | Sale | 5,919 | 14.20 | 84,049 |
| 2015-06-11 | TKAI | Sale | 27,875 | 14.20 | 395,825 |
| 2015-03-18 | TKAI | Sale | 3,000 | 14.50 | 43,500 |
| 2015-03-19 | TKAI | Sale | 46,141 | 14.50 | 669,044 |
| 2014-09-22 | TKAI | Buy | 325,000 | 15.00 | 4,875,000 |
Table 9. Insider trading of Bicycle Therapeutics Plc (BCYC) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-05-28 | BCYC | Buy | 168,630 | 14.00 | 2,360,820 |
Table 10. Insider trading of Aerpio Pharmaceuticals, Inc. (ARPO) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-04-26 | ARPO | Sale | 138,704 | 1.03 | 142,865 |
| 2019-04-25 | ARPO | Sale | 563,096 | 1.03 | 579,988 |
| 2019-04-22 | ARPO | Sale | 7,100 | .97 | 6,887 |
| 2019-04-23 | ARPO | Sale | 27,554 | 1.03 | 28,380 |
| 2019-04-24 | ARPO | Sale | 16,403 | 1.03 | 16,895 |
| 2019-04-15 | ARPO | Sale | 28,794 | .99 | 28,506 |
| 2019-04-12 | ARPO | Sale | 30,908 | 1.04 | 32,144 |
| 2019-04-11 | ARPO | Sale | 57,438 | 1.08 | 62,033 |
| 2019-04-08 | ARPO | Sale | 27,525 | 1.02 | 28,075 |
| 2019-04-09 | ARPO | Sale | 32,991 | 1.01 | 33,320 |
| 2019-04-10 | ARPO | Sale | 140,230 | 1.09 | 152,850 |
| 2019-04-05 | ARPO | Sale | 24,661 | 1.02 | 25,154 |
| 2019-04-04 | ARPO | Sale | 47,900 | 1.01 | 48,379 |
| 2019-04-03 | ARPO | Sale | 58,033 | .96 | 55,711 |
| 2019-04-01 | ARPO | Sale | 116,909 | .95 | 111,063 |
| 2019-03-29 | ARPO | Sale | 63,100 | .91 | 57,421 |
| 2019-04-02 | ARPO | Sale | 51,754 | .97 | 50,201 |
| 2019-03-28 | ARPO | Sale | 88,835 | .94 | 83,504 |
| 2019-03-27 | ARPO | Sale | 50,749 | .99 | 50,241 |
| 2019-03-26 | ARPO | Sale | 177,762 | 1.01 | 179,539 |
| 2018-08-20 | ARPO | Sale | 5,300 | 3.90 | 20,670 |
| 2017-03-15 | NONE | Buy | 560,000 | 5.00 | 2,800,000 |
Table 11. Insider trading of Proteostasis Therapeutics, Inc. (PTI) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-02-17 | PTI | Buy | 375,000 | 8.00 | 3,000,000 |
Table 12. Insider trading of Nastech Pharmaceutical Co Inc (MRNA) by Novartis Ag
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-01-25 | MRNA | Sale | 93,005 | 1.14 | 105,932 |
| 2011-01-26 | MRNA | Sale | 74,500 | 1.15 | 85,302 |
| 2011-01-21 | MRNA | Sale | 69,500 | 1.26 | 87,917 |
| 2011-01-24 | MRNA | Sale | 72,800 | 1.19 | 86,704 |
| 2011-01-19 | MRNA | Sale | 42,800 | 1.54 | 65,869 |
| 2011-01-20 | MRNA | Sale | 45,700 | 1.32 | 60,552 |
| 2011-01-20 | MRNA | Sale | 5,700 | 1.48 | 8,407 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Novartis Ag
(10% Owner of Akouos, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.